GR79710B - - Google Patents

Info

Publication number
GR79710B
GR79710B GR73297A GR830173297A GR79710B GR 79710 B GR79710 B GR 79710B GR 73297 A GR73297 A GR 73297A GR 830173297 A GR830173297 A GR 830173297A GR 79710 B GR79710 B GR 79710B
Authority
GR
Greece
Prior art keywords
compounds
formula
alpha2
antagonists
intermediates
Prior art date
Application number
GR73297A
Other languages
English (en)
Inventor
Cyrus John Ohnmacht
Original Assignee
Ici America Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici America Inc filed Critical Ici America Inc
Publication of GR79710B publication Critical patent/GR79710B/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/66Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GR73297A 1982-12-23 1983-12-20 GR79710B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8236602 1982-12-23

Publications (1)

Publication Number Publication Date
GR79710B true GR79710B (el) 1984-10-31

Family

ID=10535191

Family Applications (1)

Application Number Title Priority Date Filing Date
GR73297A GR79710B (el) 1982-12-23 1983-12-20

Country Status (7)

Country Link
EP (1) EP0115142B1 (el)
JP (1) JPS59130286A (el)
AT (1) ATE23337T1 (el)
CA (1) CA1219267A (el)
DE (1) DE3367391D1 (el)
ES (1) ES8601190A1 (el)
GR (1) GR79710B (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1216119A (en) * 1984-05-16 1987-01-06 Mitsui Chemicals, Incorporated Process for producing stretched article of ultrahigh- molecular weight polyethylene
GB8805628D0 (en) * 1988-03-09 1988-04-07 Erba Farmitalia Hypolipidaemic imidazol-2-yl-derivatives of bicyclic compounds & process for their preparation
FR2639227A1 (fr) * 1988-11-23 1990-05-25 Sanofi Sa Utilisation de derives du chromane pour le traitement des etats depressifs
JPH02218675A (ja) * 1989-02-21 1990-08-31 Nippon Kayaku Co Ltd 6―フルオロクロモン―2―カルボン酸及びその製造法
FR2763335B1 (fr) * 1997-05-16 2000-11-24 Adir Nouveaux composes heterocycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2787451B1 (fr) * 1998-12-18 2001-01-26 Adir Nouveaux composes imidazoliniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2000073269A2 (en) * 1999-06-02 2000-12-07 Regents Of The University Of Minnesota Nicotine receptor ligands
JP2002226473A (ja) * 2000-08-29 2002-08-14 Kuraray Co Ltd クロマンカルボン酸の製造方法
CZ20013076A3 (cs) * 2000-08-29 2002-04-17 Kuraray Co., Ltd. Způsob výroby chromankarboxylové kyseliny
DE10348257A1 (de) * 2003-10-16 2005-05-25 Merck Patent Gmbh Verfahren zur Herstellung von enantiomereneinen in 2-Position substituierten Chromanderivaten

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA960223A (en) * 1970-02-05 1974-12-31 Mervyn E. Peel Tetrazolyl chromones
DE2021899A1 (de) * 1970-05-05 1971-11-25 Basf Ag Sulfonsaeuregruppenhaltige Farbstoffe und deren Salze
ZA739471B (en) * 1972-12-22 1974-08-28 Hoffmann La Roche Chromane derivatives
JPS5529110B2 (el) * 1972-12-25 1980-08-01
DE2413849A1 (de) * 1974-03-22 1975-10-02 Bayer Ag Neue ungesaettigte chromanderivate
FR2436785A1 (fr) * 1978-09-25 1980-04-18 Warner Lambert Co 3-(1h-tetrazol-5-yl) chromones et leur utilisation therapeutique
DE2909601A1 (de) * 1979-03-12 1980-09-25 Basf Ag Verfahren zur herstellung von chromanderivaten
PH16249A (en) * 1980-02-04 1983-08-16 Reckitt & Colmann Prod Ltd Imidazoline derivatives,its pharmaceutical composition and method of use

Also Published As

Publication number Publication date
EP0115142A1 (en) 1984-08-08
JPS59130286A (ja) 1984-07-26
EP0115142B1 (en) 1986-11-05
ES528365A0 (es) 1985-11-01
ES8601190A1 (es) 1985-11-01
ATE23337T1 (de) 1986-11-15
CA1219267A (en) 1987-03-17
DE3367391D1 (en) 1986-12-11

Similar Documents

Publication Publication Date Title
ES2040261T3 (es) Procedimiento para preparar acidos 6-fluor-4-oxo-1,4-dihidroquinolina-3-carboxilicos sustituidos y acidos 9-fluor-3-metil-7-oxo-2,3-dihidro-7h-pirido(1,2,3-de)(1,4)benzoxazina-6-carboxilico sustituidos.
RO91075B (ro) Procedeu pentru prepararea unor-heterociclil-4-piperidinamine
CA1260471C (el)
GR79710B (el)
HUT67704A (en) Thiazolidine compounds having quinonyl group, process for preparing them and pharmaceutical compositions containing them
IL86080A (en) Substituted alkoxy-2-alkyl-indan and 1,2,3,4-tetrahydro-naphthol,process for the preparation thereof and pharmaceutical compositions comprising the same
DE3068379D1 (en) Indolobenzoxazines, processes for preparing and pharmaceutical compositions containing the same
EP0411912A3 (en) Coumarin derivatives, their preparation and their use in the treatment of cerebrovascular disorders
DE3267793D1 (en) Pyrid-3-yl or piperidin-3-yl-oxo-2-indole derivatives, their salts, process for their preparation, compositions containing them and their uses as medicines
IL93161A0 (en) 3-phenyl-5,6-dihydrobenz(c)acridine-7-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
DE3477380D1 (en) Novel benzothiazepine derivatives, processes for preparing the same and pharmaceutical compositions
PT86282A (en) Novel anthracyclinederivates a process for preparing and pharmaceutical compounds containing them
PT76903A (en) Process for preparing novel derivatives of guanine and of pharmaceutical compositions containing the same
SG43191G (en) Isoxazole derivatives, process for their preparation and pharmaceutical compositions containing them
SE8803765L (sv) Nya isopolypeptider samt foerfarande foer framstaellning av desamma
HUT54682A (en) Process for producing 13-bromine- and 13,14-dibromine-ergoline derivatives and pharmaceutical preparatives containing these compounds
PH22441A (en) Quinate salts of the antimaterial compound mefloquine
ZA844850B (en) Novel 3-(4'-aminobutylamino)-propylamino-bleomycin derivatives,a process for their preparation and their use as medicaments